April 21st 2025
An oral dose of 0.6 mg per 5 mL of colchicine could aid individuals who have trouble with swallowing pills.
Adult patients with refractory chronic gout (RCG) treated bi-weekly with Krystexxa (pegloticase) experienced statistically significant and clinically meaningful improvements in health-related quality of life (HRQOL), pain, and physical function, according to an analysis in The Journal of Rheumatology.
Read More
Specialty Pharmacy Management of Gout
February 20th 2012New drugs and drugs in the pipeline for gout have changed the treatment for this painful disease, one of the oldest documented diseases. Here's an update on what's new and what specialty pharmacists need to know as they counsel patients for gout.
Read More